Skip to content

Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet

Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07379216
Enrollment
30
Registered
2026-01-30
Start date
2026-01-24
Completion date
2026-06-01
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-Oxidative Stress, Skin Condition

Keywords

Vitamin C supplement, Glutathione supplement

Brief summary

The objective of this study is to evaluate the effect of liquid vitamin C and glutathione supplements on human skin condition improvement and anti-oxidation.

Detailed description

This study is a single-center, placebo-controlled, double-blinded, parallel human trial designed to evaluate the skin beauty and anti-oxidant effect of liquid vitamin C and glutathione supplements. Healthy adult participants aged 18-65 years will be enrolled. Participants will be informed to consume test samples daily for 12 consecutive weeks. Skin measurement and self-assessment questionnaires will be conducted at baseline (before intake), after 4, 8 weeks, and 12 weeks of consumption. Fasting blood samples will be collected at baseline and after 12 weeks of consumption.

Interventions

DIETARY_SUPPLEMENTPlacebo sachet

consume 1 sachet of the test samples daily for 12 consecutive weeks

DIETARY_SUPPLEMENTVitamin C and Glutathione Liquid Sachet

consume 1 sachet of the test samples daily for 12 consecutive weeks

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male or female adults, aged 18-65 years old; * Commitment not to use products having activity comparable with that of the product to be tested during the study period; * Free of any dermatological or systemic disorder that would interfere with results.

Exclusion criteria

* Subject with obvious skin surface damage; * Subject who had oral or topical medication which may affect skin condition within 1 month; * Individuals with known allergies to cosmetics, medications, or foods (especially those allergic to legumes/soy); * Pregnant or breastfeeding individuals; * Received facial laser therapy, chemical peeling in the past 2 months. * Individuals unwilling to allow publication or public disclosure of photographs taken as part of the study results

Design outcomes

Primary

MeasureTime frameDescription
The change of skin toneChange from Baseline skin tone at 12 weeksChroma Meter MM500 was utilized to measure face skin tone. Units: Individual Typology Angle (ITA°)
The change of visible spotsChange from Baseline visible spots at 12 weeksVISIA Complexion Analysis was utilized to measure visible spots on face. Units: the amount of detectable visible spots
The change of UV spotsChange from Baseline UV spots at 12 weeksVISIA Complexion Analysis was utilized to measure UV spots on face. Units: the amount of detectable UV spots

Secondary

MeasureTime frameDescription
The change of skin hydrationChange from Baseline skin hydration at 12 weeksCorneometer® CM825 (CK, Germany) was utilized to measure skin surface hydation. Units: arbitrary Corneometer® units 0-120.
The change of skin rednessChange from Baseline skin redness at 12 weeksChroma Meter MM500 was utilized to measure face skin redness. Units: a\* value
The change of skin melanin indexChange from Baseline skin melanin index at 12 weeksMexameter® MX18 (CK, Germany) was utilized to measure face skin melanin level. Units: arbitrary units
The change of skin elasticityChange from Baseline skin elasticity at 12 weeksSkin elasticity (Softplus, Italy) was utilized to measure face skin elasticity. Units: arbitrary units
The change of brown spotsChange from Baseline brown spots at 12 weeksVISIA Complexion Analysis was utilized to measure brown spots on face. Units: the amount of detectable brown spots
The change of wrinkles around the eyesChange from Baseline wrinkles around the eyes at 12 weeksVISIA Complexion Analysis was utilized to measure wrinkles around the eyes. Units: the amount of detectable wrinkles
The change of skin textureChange from Baseline skin texture at 12 weeksVISIA Complexion Analysis was utilized to measure skin texture. Units: arbitrary units
The change of skin collagen densityChange from Baseline skin collagen density at 12 weeksDermaLab® Series SkinLab Combo was utilized to measure skin collagen density. Units: arbitrary units
The change of total antioxidation capacity (TAC)Change from Baseline TAC at 12 weeksA fasting blood sample will be collected for TAC testing.
The change of Superoxide Dismutase (SOD)Change from Baseline SOD at 12 weeksA fasting blood sample will be collected for SOD testing.
The change of Glutathione S-transferase-Red Blood Cells (GST-RBC)Change from Baseline GST-RBC at 12 weeksA fasting blood sample will be collected for GST-RBC testing.
The change of Malondialdehyde (MDA)Change from Baseline MDA at 12 weeksA fasting blood sample will be collected for MDA testing.

Countries

Taiwan

Contacts

CONTACTChia-Hua Liang, Ph.D.
tinna_ling@mail.cnu.edu.tw+886-06-2664911
CONTACTPing Lin
candice.lin@tci-bio.com+886-02-87977811
PRINCIPAL_INVESTIGATORChia-Hua Liang, Ph.D.

Chia Nan University of Pharmacy & Science

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026